Randomized Clinical Trial
Copyright ©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10234-10241
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10234
Figure 1
Figure 1 Flow schematic of the study included in intention-to-treat and per-protocol analyses. 1Rabeprazole 20 mg twice a day, amoxicillin 1 g twice a day, moxifloxacin 400 mg once a day, clarithromycin 500 mg twice a day, metronidazole 500 mg twice a day. MBST: 14-d moxifloxacin-based sequential therapy; Hybrid: 14-d hybrid therapy; ITT: Intention-to-treat; PP: Per-protocol.